305
Views
1
CrossRef citations to date
0
Altmetric
Case Reports

Infant-Type Hemispheric Glioma in a Chinese Girl: A Newly Defined Entity

ORCID Icon, , , &
Pages 114-122 | Received 17 Mar 2022, Accepted 29 Mar 2022, Published online: 11 Apr 2022

References

  • Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231–51. doi:10.1093/neuonc/noab106. Cited in: PubMed; PMID: 34185076.
  • Guerreiro Stucklin AS, Ryall S, Fukuoka K, Zapotocky M, Lassaletta A, Li C, Bridge T, Kim B, Arnoldo A, Kowalski PE, et al. Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas. Nat Commun. 2019;10(1):4343. doi:10.1038/s41467-019-12187-5. Cited in: PubMed; PMID: 31554817.
  • Clarke M, Mackay A, Ismer B, Pickles JC, Tatevossian RG, Newman S, Bale TA, Stoler I, Izquierdo E, Temelso S, et al. Infant high-grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes. Cancer Discov. 2020;10(7):942–63. doi:10.1158/2159-8290.CD-19-1030. Cited in: PubMed; PMID: 32238360.
  • Ng A, Levy ML, Malicki DM, Crawford JR. Unusual high-grade and low-grade glioma in an infant with PPP1CB-ALK gene fusion. BMJ Case Rep. 2019;12(2):e228248. Cited in: PubMed; PMID: 30709888. doi:10.1136/bcr-2018-228248.
  • Ziegler DS, Wong M, Mayoh C, Kumar A, Tsoli M, Mould E, Tyrrell V, Khuong-Quang DA, Pinese M, Gayevskiy V, et al. Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma. Br J Cancer. 2018;119(6):693–6. doi:10.1038/s41416-018-0251-2. Cited in: PubMed; PMID: 30220707.
  • Cocce MC, Mardin BR, Bens S, Stutz AM, Lubieniecki F, Vater I, Korbel JO, Siebert R, Alonso CN, Gallego MS. Identification of ZCCHC8 as fusion partner of ROS1 in a case of congenital glioblastoma multiforme with a t(6;12)(q21;q24.3). Genes Chromos Cancer. 2016;55(9):677–87. doi:10.1002/gcc.22369. Cited in: PubMed; PMID: 27121553.
  • Olsen TK, Panagopoulos I, Meling TR, Micci F, Gorunova L, Thorsen J, Due-Tonnessen B, Scheie D, Lund-Iversen M, Krossnes B, et al. Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity? Neuro Oncol. 2015;17(10):1365–73. doi:10.1093/neuonc/nov039. Cited in: PubMed; PMID: 25795305.
  • Torre M, Vasudevaraja V, Serrano J, DeLorenzo M, Malinowski S, Blandin AF, Pages M, Ligon AH, Dong F, Meredith DM, et al. Molecular and clinicopathologic features of gliomas harboring NTRK fusions. Acta Neuropathol Commun. 2020;8(1):107. doi:10.1186/s40478-020-00980-z. Cited in: PubMed; PMID: 32665022.
  • Hélias C, Leymarie V, Entz-Werle N, Falkenrodt A, Eyer D, Costa JA, Cherif D, Lutz P, Lessard M. Translocation t(5;14)(q35;q32) in three cases of childhood T cell acute lymphoblastic leukemia: a new recurring and cryptic abnormality. Leukemia. 2002;16(1):7–12. doi:10.1038/sj.leu.2402347. Cited in: PubMed; PMID: 11840257.
  • Morris LG, Kaufman AM, Gong Y, Ramaswami D, Walsh LA, Turcan Ş, Eng S, Kannan K, Zou Y, Peng L, et al. Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation. Nat Genet. 2013;45(3):253–61. doi:10.1038/ng.2538. Cited in: PubMed; PMID: 23354438.
  • Baccarani M, Rosti G, Soverini S. Chronic myeloid leukemia: the concepts of resistance and persistence and the relationship with the BCR-ABL1 transcript type. Leukemia. 2019;33(10):2358–64. doi:10.1038/s41375-019-0562-1. Cited in: PubMed; PMID: 31455852.
  • Nielsen SV, Hartmann-Petersen R, Stein A, Lindorff-Larsen K. Multiplexed assays reveal effects of missense variants in MSH2 and cancer predisposition. PLoS Genet. 2021;17(4):e1009496. doi:10.1371/journal.pgen.1009496. Cited in: PubMed; PMID: 33886538.
  • Buisson R, Dion-Côté AM, Coulombe Y, Launay H, Cai H, Stasiak AZ, Stasiak A, Xia B, Masson JY. Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination. Nat Struct Mol Biol. 2010;17(10):1247–54. doi:10.1038/nsmb.1915. Cited in: PubMed; PMID: 20871615.
  • Jones C, Karajannis MA, Jones DTW, Kieran MW, Monje M, Baker SJ, Becher OJ, Cho YJ, Gupta N, Hawkins C, et al. Pediatric high-grade glioma: biologically and clinically in need of new thinking. Neuro Oncol. 2017;19(2):153–61. doi:10.1093/neuonc/now101. Cited in: PubMed; PMID: 27282398.
  • Pearce J, Khabra K, Nanji H, Stone J, Powell K, Martin D, Zebian B, Hettige S, Reisz Z, Bodi I, et al. High grade gliomas in young children: The South Thames Neuro-Oncology unit experience and recent advances in molecular biology and targeted therapies. Pediatr Hematol Oncol. 2021;38(8):707–21. doi:10.1080/08880018.2021.1907493. Cited in: PubMed; PMID: 33900873.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.